ABBV
AbbVie Inc.C5415-min delayed · EOD close261.72 +0.67% upas of 2026-09-02mkt cap $462B
Pharmaceutical Preparations · SIC 2834 · CIK 0001551152
Quality score
54/100
C
Growth73
Business quality57
missing: grossMargin, roe
Financial healthno data
missing: debtToEquity, cashToLiabilities
Valuation34
missing: pbRatio
Computed from filed fundamentals against fixed reference bands. Not a recommendation, and not a peer percentile.
The read
Mixed picture
Uneven
Strongest on growth (73), weakest on valuation (34). The composite is the mean of the sub-scores that could be computed. 5 inputs were unavailable in the filings, so the score reflects what was reported.
Revenue growth
14.3%
year over year
Earnings growth